Client: Novartis
REF: 20900


Novartis is a global leader in the discovery, development, manufacture and marketing of innovative healthcare products. Headquartered in Basel, Switzerland, the company employs over 125,000 associates located in over 140 countries, with annual revenue of $48.677 billion as of 2019, and market capitalization valued at $205.32 billion as of April 2020.

Covering the full product lifecycle, including cutting edge research geared towards breakthrough drug discovery, extensive clinical trials and successful product launches, Novartis boasts an enviable product range in a diverse spectrum of Disease Areas: Cardiovascular, Renal & Metabolism, Immunology & Dermatology, Neuroscience, Musculoskeletal Diseases, Ophthalmology, Respiratory and Cancer.

The company’s recent moves in the areas of gene therapies, radioligand therapies and digital health reflect its position at the forefront of scientific discovery. To develop breakthrough therapies that can help change the practice of medicine, Novartis attracts the best industry talent, collaborates with leading technology partners, and pursue acquisitions to strengthen and expand high-tech therapy platforms.



As part of their continued drive for real world impact to their work, Novartis is now offering an exciting opportunity for a patent attorney to contribute to the company’s vision to be “a trusted leader in changing the practice of medicine.” In particular, the successful candidate will join the global R&D Intellectual Property as part of the Musculoskeletal Diseases franchise in the company’s headquarters in Basel, to continue to enhance protection of innovative medicines for patients.

The role of a patent attorney within Novartis is diverse and demanding, including not just substantive patent drafting and prosecution, IP strategic counselling and portfolio management work, but extending to broader demands in line with the organization’s wider commercial objectives, including: IP due diligence work for M&A activities; IP transactional agreement work; in- and out-licensing; IP litigation support; patent extension matters and regional exclusivity concerns surrounding development of early stage therapies.



The successful candidate is likely to fulfil the following criteria:

  • Possess an excellent educational background to degree level or beyond in Biology, Biotechnology, Biochemistry, or a relevant subject area; ideally coupled with practical patent knowledge of biologics, antibodies and/or gene therapy;
  • Be a fully qualified European Patent Attorney with three to eight years’ of post-qualification experience, preferably in an industry setting – though those with suitable experience in private practice will also be considered;
  • Demonstrate strong customer-service focus to build and sustain good working partnerships with key stakeholders and project teams;
  • Be an excellent communicator, able to convey information to professionals at all levels and across different business areas;
  • Well-developed research and critical thinking skills, and sound decision-making abilities, with attention-to-detail to produce consistently accurate work;
  • Have a solution-orientated working style, be adaptable and able to cope with changes and deal with ambiguities;
  • Be fluent in English as the working language of the company, with additional European languages such as German also beneficial.

If you would like to explore this opportunity further, please contact

Rene Chung


Signup for job alerts Click here